Ciechanover Institute of Precision and Regenerative Medicine of the Chinese University of Hong Kong, Shenzhen was established on March 22nd, 2018. The Institute led by Professor Aaron Ciechanover, Nobel laureate in Chemistry in 2004, is the third Nobel Laureate Research Institute of the University.

Professor Aaron Ciechanover received Nobel Prize in Chemistry in 2004, and serves as Distinguished Professor of Research at the Israel Institute of Technology. He is a foreign member of the USA National Academy of Sciences, an honorary Fellow of the American Academy of Arts and Sciences and a foreign member of the Chinese Academy of Sciences.

Ciechanover Institute of Precision and Regenerative Medicine has two major research focuses: precision medicine for the diagnosis and treatment of cancer and infectious disease; regenerative medicine for stem cell based treatment of stroke, Parkinson’s disease, Alzheimer’s disease, diabetes, etc. Precision medicine is an extremely important and hot frontier area that combines and transcends many research disciplines such as medicine, pharmaceutics, life science, genomics, big data and artificial intelligence. Regenerative medicine has become a vitally important area of medical research, development and commercialization.

The Institute will seize the strategic opportunity vital to human health and high technology development and fully capitalize on the existing technological advantages and global influence of many world-renowned scientists of the Institute to become a world-class research and development organization within a short period of time. Through close collaboration with other research platforms of CUHK-Shenzhen such as Institute of Robot and Intelligent Manufacturing, Shenzhen Research Institute of Big Data, Kobilka Institute of Innovative Drug Discovery, Warshel Institute for Computational Biology and with many companies in Shenzhen on technology transfer and commercialization, the Institute will play a leading role in the development of world-class biopharmaceutical and health industries in Shenzhen Municipality. The Institute also aims to explore new collaborative models of Shenzhen and Hong Kong in education and research under the national development strategy of the Greater Bay Area of Guangdong-Hong Kong-Macau. For example, the Institute is building close and complementary cooperation with the Institute for Tissue Engineering and Regenerative Medicine (iTERM) of CUHK, in order to advance the fundamental and applied research in steam cell and regenerative medicine.